OMER (STOCKS)
Omeros Corporation
$11.345000
+0.115000 (+1.02%)
Prev close: $11.230000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Gregory A. Demopulos
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $811.10M
- Employees
- 202
- P/E (TTM)
- -5.67
- P/B (TTM)
- -3.64
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
5
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.47 | $-0.45 | -0.0161 | -3.55% |
|
Jun 2025 (Q2)
|
$-0.43 | $-0.49 | +0.0606 | +12.35% |
|
Mar 2025 (Q1)
|
$-0.58 | $-0.58 | -0.0020 | -0.35% |
|
Dec 2024 (Q4)
|
$-0.54 | $-0.79 | +0.2531 | +31.91% |
Financial Statements
| Revenues | $0.00 |
| Costs And Expenses | $129.38M |
| Selling, General, and Administrative Expenses | $44.21M |
| Research and Development | $85.17M |
| Operating Income/Loss | -$129.38M |
| Income/Loss From Continuing Operations After Tax | -$121.24M |
| Income/Loss From Continuing Operations Before Tax | -$103.30M |
| Income/Loss From Discontinued Operations Net Of Tax | $80.00K |
| Net Income/Loss | -$121.16M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$121.16M |
| Net Income/Loss Available To Common Stockholders, Basic | -$121.16M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.03 |
| Basic Average Shares | 182,844,356 |
| Assets | $185.71M |
| Current Assets | $71.81M |
| Cash | $36.10M |
| Accounts Receivable | $6.91M |
| Other Current Assets | $28.80M |
| Noncurrent Assets | $113.90M |
| Fixed Assets | $2.01M |
| Other Non-current Assets | $111.89M |
| Liabilities | $406.18M |
| Current Liabilities | $80.76M |
| Accounts Payable | $12.50M |
| Wages | $12.14M |
| Other Current Liabilities | $56.12M |
| Noncurrent Liabilities | $325.43M |
| Long-term Debt | $154.94M |
| Other Non-current Liabilities | $170.49M |
| Equity | -$220.48M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$220.48M |
| Liabilities And Equity | $185.71M |
| Net Cash Flow From Operating Activities | -$105.23M |
| Net Cash Flow From Operating Activities, Continuing | -$105.23M |
| Net Cash Flow From Investing Activities | $87.93M |
| Net Cash Flow From Investing Activities, Continuing | $87.93M |
| Net Cash Flow From Financing Activities | $18.18M |
| Net Cash Flow From Financing Activities, Continuing | $18.18M |
| Net Cash Flow | $874.00K |
| Net Cash Flow, Continuing | $874.00K |
| Comprehensive Income/Loss | -$121.16M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$121.16M |
| Other Comprehensive Income/Loss | $0.00 |